Abstract

It is recognized that developing valid animal models is essential for the research on the neurobiological mechanisms of (and treatments for) psychiatric disorders, even when these are as complex as schizophrenia. To be considered a valid analogue of the disorder, a given model should present good face validity (i.e. similarity of symptoms), good predictive validity (i.e. similarity of treatment effects and potential for discovering novel treatments) and enough construct validity (i.e. the model should help discover neurobiological mechanisms underlying the disorder or some relevant symptoms). The complexity of symptoms (positive, negative and cognitive) of schizophrenia makes it a very difficult task for a model to mimic all the main features of the disorder, but some rodent (mouse and rat) models have behavioural and even neurobiological phenotype characteristics resembling positive-like symptoms, cognitive symptoms and some neurochemical features of schizophrenia. As several recent works have already reviewed the main behavioural and developmental models, as well as the most used drug-induced, lesion-induced and genetic mouse models, the present review focuses on describing the most relevant genetically-based rat models of schizophrenia-relevant symptoms. Thus, we discuss several selective breeding programs leading to rat lines/strains which present impaired prepulse inhibition (PPI) of the acoustic startle response and (in some cases) latent inhibition deficits (both of which may be considered as endophenotypes of schizophrenia related with pre-attentive processes and attention, respectively), as well as other schizophrenia-relevant symptoms (e.g. learning deficits). Evidence is presented for the effects of genetic background on PPI (and other symptoms/phenotypes), as well as for environmental influences on genetic predisposition to enhanced apomorphine (mixed dopamine receptor agonist) effects. Some of the described rat models appear to present face validity and, to a certain extent, construct validity. While efforts should be made to evaluate the predictive validity of these genetic rat models, we propose that they have the advantage (over mouse knockouts, for example) of better representing “normal” genetic, neurobiological and phenotype variation, thus allowing the study of associations among them by means of genetic mapping or gene expression studies.

Highlights

  • After over 100 years of systematic efforts to unravel the origin of schizophrenias, the cause of these disorders remains unknown

  • Most of the psychogenetic rat models discussed in the present work appear to present good face validity, as they often show hyperlocomotion and/or enhanced locomotor responses to DA agonists, impairments in prepulse inhibition (PPI), and in some cases impaired latent inhibition and/or deficits in some cognitive/executive functions

  • Construct validity is still better in those models presenting decreased neuregulin-1 methylation or alterations of both 5-HT2A receptors in frontal cortex and mGluR2 expression in frontal cortex, hippocampus and striatum

Read more

Summary

Introduction

After over 100 years of systematic efforts to unravel the origin of schizophrenias, the cause of these disorders remains unknown. The schizophrenias are a group of chronic mental disorders, often severely disabling, affecting about 1% of the world population They constitute one of the major challenges for health systems and social assistance by the degree of disability and the care and expense required. They consist of a collection of signs and symptoms that are diagnosed by prototypical manifestations of mental confusion or psychosis which commonly progress towards a debilitating cognitive disorganization. The “serotonin hypothesis” of psychosis comes from the finding that hallucinogens (that mimic some positive schizophrenic symptoms), such as LSD, act as agonists at 5-HT2ARs (serotonin 2A receptors), while atypical neuroleptics This, jointly with the anti-schizophrenic-like effects of some mGluR2 agonist (e.g. LY2140023) has led to the “glutamate hypothesis” of psychosis ([5]-[8])

Rodent Models and Behaviors Relevant to Schizophrenia
Genetic Rat Models of Schizophrenia
Genetic Background Effects on PPI Phenotypes Using “Standard” Rat Strains
Differences among Other Rat Strains in Schizophrenia-Relevant Symptoms
Selective Breeding of Reduced Sensorimotor Gating
The APO-SUS and APO-UNSUS Rats
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.